BackJCR Pharmaceuticals , Ltd. Overview

JCR Pharmaceuticals , Ltd. Current Assets

Latest current assets for JCRRF: $53B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$53.36B
↑ 1.35% YoYΔ $708.30M vs prior year quarter

Peer trimmed avg / median

Loading

JCR Pharmaceuticals , Ltd. Current Assets History

Loading

JCR Pharmaceuticals , Ltd. vs. peers: Current Assets Comparison

Loading

JCR Pharmaceuticals , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

JCR Pharmaceuticals , Ltd. (JCRRF) FAQ

As of the most recent data (June 2026), JCRRF shows a current assets of $53B. That compares with $53B in the prior-year period — up 1.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JCRRF's current assets is now $53B (was $53B) — a 1.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether JCR Pharmaceuticals , Ltd. is outperforming or lagging.

Tracking JCRRF's current assets over time shows whether JCR Pharmaceuticals , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $53B That compares with $53B in the prior-year period — up 1.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has JCR Pharmaceuticals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $53B) with ownership activity and broader fundamentals.